SER-262

N/A

Report date: 2023/08/01 20:00:44

Base Information

Drug NameSER-262
Drug Alias NameSER262SER-262
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionBacteria replacementsMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSeres Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeres Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A